Loss of Skeletal Muscle Inositol Polyphosphate Multikinase Disrupts Glucose Regulation and Limits Exercise Capacity
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062395 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ji-Hyun Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, MD 21218, USA. Hauptthemen laut MEDLINE: Muscle, Skeletal, Glucose, Phosphotransferases (Alcohol Group Acceptor), Physical Conditioning, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH/NIDDK, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK).
Abstract (Originalsprache)
Inositol phosphates are critical signaling messengers involved in a wide range of biological pathways, and inositol polyphosphate multikinase (IPMK) functions as a rate-limiting enzyme for inositol polyphosphate metabolism. IPMK has been implicated in cellular metabolism, but its function at the systemic level is still poorly understood. Since skeletal muscle is a major contributor to energy homeostasis, we have developed a mouse model in which skeletal muscle IPMK is specifically deleted and examined how a loss of IPMK affects whole-body metabolism. Here, we report that skeletal-muscle-specific IPMK knockout mice exhibited a ~12% increase in body weight compared to WT controls (p < 0.05). These mice also showed a significantly impaired glucose tolerance, as indicated by their ~50% higher blood glucose levels during GTT. Additionally, exercise capacity was reduced by ~45% in IPMK-MKO mice, demonstrating a decline in endurance. Moreover, these metabolic alterations were accompanied by a 2.5-fold increase in skeletal muscle triglyceride accumulation, suggesting impaired lipid metabolism. Further analysis revealed that IPMK-deficient myocytes exhibited 30% lower β-oxidation rates. Thus, our results suggest that IPMK mediates whole-body metabolism by regulating muscle metabolism and may be potentially targeted for the treatment of metabolic syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, MD 21218, USA.
ORCID-Profile: Ji-Hyun Lee, Ik-Rak Jung, Frederick Anokye-Danso, Sangwon F Kim
Förderung
- NIDDK NIH HHS
- NIH/NIDDK
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)
Zitieren
APA
Lee, J. H., Jung, I. R., Tu-Sekine, B., Jin, S., Anokye-Danso, F., Ahima, R. S., & Kim, S. F. (2025). Loss of Skeletal Muscle Inositol Polyphosphate Multikinase Disrupts Glucose Regulation and Limits Exercise Capacity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062395
Vancouver
Lee JH, Jung IR, Tu-Sekine B, Jin S, Anokye-Danso F, Ahima RS, et al. Loss of Skeletal Muscle Inositol Polyphosphate Multikinase Disrupts Glucose Regulation and Limits Exercise Capacity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062395
BibTeX
@article{Lee2025,
author = {Lee, Ji-Hyun and Jung, Ik-Rak and Tu-Sekine, Becky and Jin, Sunghee and Anokye-Danso, Frederick and Ahima, Rexford S and Kim, Sangwon F},
title = {Loss of Skeletal Muscle Inositol Polyphosphate Multikinase Disrupts Glucose Regulation and Limits Exercise Capacity},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062395}
}
EUVIMED